AMTX vs HDSN

AMTX exhibits weak financial health with a Piotroski F-Score of 4/9, indicating a fragile operational foundation. The absence of an Altman Z-Score and negative profitability metrics—especially a -38.96% profit margin and -8.96% ROA—signal severe operational distress. Despite a 14.2% YoY revenue growth and recent positive EPS surprises, the company remains unprofitable with negative cash flow and extreme liquidity issues (current ratio of 0.07). The stock trades at a price/sales of 0.77, but this is misleading given the lack of sustainable earnings and deteriorating balance sheet. The 52-week price range of $1.22–$3.66 reflects high volatility and speculative risk.

HDSN exhibits severe fundamental deterioration, highlighted by a weak Piotroski F-Score of 2/9 and a catastrophic YoY EPS decline of 116.7%. While the company maintains a clean balance sheet with very low debt (D/E 0.02) and trades below its Graham Number ($6.98), the divergence between strong revenue growth (28.2%) and negative operating margins (-16.23%) suggests an unsustainable operational model. Insider selling and a bearish technical trend further undermine the optimistic analyst target of $9.00.